Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

422.90INR
15 Feb 2019
Change (% chg)

Rs-18.00 (-4.08%)
Prev Close
Rs440.90
Open
Rs440.75
Day's High
Rs440.75
Day's Low
Rs416.45
Volume
10,206,627
Avg. Vol
12,064,672
52-wk High
Rs679.30
52-wk Low
Rs370.20

Select another date:

Tue, Feb 12 2019

Photo

Sun Pharma third-quarter profit jumps four-fold on strong U.S. show

India's largest drugmaker by market value Sun Pharmaceutical Industries Ltd posted a nearly four-fold jump in quarterly profit on Tuesday, breezing past estimates on strong sales in the U.S. market.

UPDATE 1-India's Sun Pharma Q3 profit jumps four-fold on strong U.S. show

Feb 12 India's largest drugmaker by market value Sun Pharmaceutical Industries Ltd posted a nearly four-fold jump in quarterly profit on Tuesday, breezing past estimates on strong sales in the U.S. market.

India's Sun Pharma Q3 profit rises nearly four-fold, beats estimate

Feb 12 Sun Pharmaceutical Industries Ltd , India's largest drugmaker by market value, posted a nearly four-fold jump in quarterly profit on Tuesday, beating estimates.

MEDIA-India's market regulator probing Sun Pharma over whistleblower charges - Mint

- Note: Reuters has not verified this story and does not vouch for its accuracy

Sun Pharma takes steps to ease governance concerns; shares rally

India's top drugmaker by market value Sun Pharmaceutical Industries announced on Tuesday a new local distributor and other measures in a bid to ease investor concerns over its corporate governance, sending its shares up more than 6 percent.

UPDATE 2-India's Sun Pharma takes steps to ease governance concerns; shares rally

* Shares jump over 6 pct (Adds analyst comments, updates share move)

India's Sun Pharma to make unit distributor for local formulations biz

Jan 22 Indian drugmaker Sun Pharmaceutical Industries Ltd said https://www.nseindia.com/corporate/SUNPHARMA456_22012019083723_IntimationSE20190122_001.pdf on Tuesday it will make its unit the new distributor for its domestic formulations business, replacing Aditya Medisales.

MEDIA-Promoters of India's Sun Pharma pledged firm's shares for Suraksha Realty - Economic Times

- Note: Reuters has not verified this story and does not vouch for its accuracy

Sun Pharma asks SEBI to examine media report

Sun Pharmaceutical Industries Ltd on Friday asked India's capital markets regulator to look into a media report about an alleged complaint by a whistleblower that led to a sell-off in the company's shares.

India's Sun Pharma asks regulator to examine media report

Jan 18 Sun Pharmaceutical Industries Ltd on Friday asked India's capital markets regulator to look into a media report about an alleged complaint by a whistleblower that led to a sell-off in the company's shares.

Select another date: